Hridayam Pharmaceuticals Private Limited
About Hridayam Pharmaceuticals Private Limited
Data last updated:
Hridayam Pharmaceuticals Private Limited is a private limited company based in Zundal, Gujarat, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 30 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2019PTC106333. Its GSTIN is 24AAECH7953E1ZL (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepali Paresh Ganatra and Paresh Dhirajlal Ganatra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 1101 Savya Skyz Opp. Santavan Party Plot Zundal, Gujarat, India – 382421.
As per the financials filed for FY 2023, the company reported a revenue of ₹17.05 Lakh, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹2,048 (net margin 0.1%) and EBITDA of ₹4.09 Lakh (EBITDA margin 24%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Hridayam Pharmaceuticals Private Limited's registered office is in Zundal, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressB – 1101 Savya Skyz Opp. Santavan Party Plot Zundal, Gujarat, India – 382421
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Hridayam Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hridayam Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hridayam Pharmaceuticals Private Limited, buy the company report.
Financials of Hridayam Pharmaceuticals Private Limited
FY 2025 filings availableHridayam Pharmaceuticals Private Limited reported revenue of ₹17.05 Lakh (up 26% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 35% over three years, including 26% growth in the latest year. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,048 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hridayam Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hridayam Pharmaceuticals Private Limited
Hridayam Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepali Paresh Ganatra | Director | 30 Jan 2019 | 7 Years 9 Months | Current |
| Paresh Dhirajlal Ganatra | Director | 30 Jan 2019 | 7 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Hridayam Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hridayam Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hridayam Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECH7953E1ZL | Gujarat | Active | 06 Feb 2019 |
To see the full GST registrations and return filing status of Hridayam Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hridayam Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Deepali Paresh Ganatra was appointed as Director on 30 Jan 2019.
Frequently asked questions
Hridayam Pharmaceuticals is an active private limited company based in Zundal, Gujarat, India. The company works in specialty, within the trading industry. It was incorporated on 30 January 2019 (7+ years old) and is registered under CIN U51909GJ2019PTC106333.
Hridayam Pharmaceuticals has 2 current directors:
- Deepali Paresh Ganatra - Director
- Paresh Dhirajlal Ganatra - Director
The latest financial statements of Hridayam Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Hridayam Pharmaceuticals is 24AAECH7953E1ZL, registered in Gujarat.
The CIN (Corporate Identification Number) of Hridayam Pharmaceuticals is U51909GJ2019PTC106333. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hridayam Pharmaceuticals was incorporated on 30 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Deepali Paresh Ganatra was appointed as Director on 30 Jan 2019. Paresh Dhirajlal Ganatra was appointed as Director on 30 Jan 2019.
The registered office of Hridayam Pharmaceuticals is at B – 1101 Savya Skyz Opp. Santavan Party Plot Zundal, Gujarat, India – 382421.
Hridayam Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Hridayam Pharmaceuticals is compliant as of 04 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
